BioSyent Inc. (CVE:RX – Get Rating) crossed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of C$7.37 and traded as high as C$7.40. BioSyent shares last traded at C$7.30, with a volume of 743 shares trading hands.
BioSyent Stock Performance
The company’s fifty day simple moving average is C$7.37 and its two-hundred day simple moving average is C$7.37. The company has a market capitalization of C$88.33 million, a price-to-earnings ratio of 14.90 and a beta of 0.78. The company has a debt-to-equity ratio of 4.36, a quick ratio of 6.91 and a current ratio of 7.93.
BioSyent Company Profile
BioSyent Inc, a specialty pharmaceutical company, sources, acquires or in-licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX 150, an oral hematinic; FeraMAX Powder, a water soluble oral iron supplement, which helps the body form red blood cells; and FeraMAX Pd Therapeutic 150 for the prevention and treatment of iron deficiency anemia.
Featured Articles
- Don’t Miss Out: $2 Trillion Could be Headed to the Banking Sector
- A Weakening Economy Suggests Caution Before Buying Five Below
- Williams-Sonoma: Time To Buy At Rock-Bottom Prices
- Why DraftKings Could Keep Outperforming in 2023
- Charles Schwab And The Safest 30% You Can Make This Year
Receive News & Ratings for BioSyent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSyent and related companies with MarketBeat.com's FREE daily email newsletter.
